Artiva Accounts Payable from 2010 to 2025

ARTV Stock   6.53  0.25  3.69%   
Artiva Biotherapeutics, Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Artiva Biotherapeutics, Common owes to suppliers or vendors for products or services received but not yet paid for. It represents Artiva Biotherapeutics,'s short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
552.6 K
Current Value
1.1 M
Quarterly Volatility
604.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Artiva Biotherapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artiva Biotherapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 3.1 M, Interest Income of 3.1 M or Depreciation And Amortization of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.66, Dividend Yield of 0.0 or Days Sales Outstanding of 20.93. Artiva financial statements analysis is a perfect complement when working with Artiva Biotherapeutics, Valuation or Volatility modules.
  
Check out the analysis of Artiva Biotherapeutics, Correlation against competitors.

Latest Artiva Biotherapeutics,'s Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Artiva Biotherapeutics, Common over the last few years. An accounting item on the balance sheet that represents Artiva Biotherapeutics, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Artiva Biotherapeutics, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Artiva Biotherapeutics,'s Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artiva Biotherapeutics,'s overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Artiva Accounts Payable Regression Statistics

Arithmetic Mean1,776,788
Geometric Mean1,634,631
Coefficient Of Variation34.01
Mean Deviation514,542
Median2,151,000
Standard Deviation604,299
Sample Variance365.2B
Range1.6M
R-Value(0.79)
Mean Square Error145B
R-Squared0.63
Significance0.0002
Slope(100,706)
Total Sum of Squares5.5T

Artiva Accounts Payable History

20251.1 M
2024552.6 K
2023614 K
20221.1 M
20211.4 M

About Artiva Biotherapeutics, Financial Statements

Artiva Biotherapeutics, investors use historical fundamental indicators, such as Artiva Biotherapeutics,'s Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Artiva Biotherapeutics,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable552.6 K1.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Artiva Stock Analysis

When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.